Learn More
Medchemexpress LLC Clz-8 (compound 8) | 678158-55-9 | 99.1% | 50 MG

Supplier: Medchemexpress LLC HY12262750MG
CLZ-8 is an orally active Mcl-1-PUMA interface inhibitor (Compound 8) used in preclinical research to modulate apoptosis; reported Ki = 0.3 μM and shows protective and anti-radiation effects in cell and animal studies.
- Orally active Mcl-1-PUMA interface inhibitor with reported Ki = 0.3 μM.
- Reduces PUMA-dependent apoptosis and deactivates Mcl-1-mediated anti-apoptosis.
- High-purity solid suitable for biochemical and cellular assays.
- Available in small research packs for laboratory use.
- Recommended storage: powder at -20°C for long-term stability.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.